Login / Signup

Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer.

Pimrapat GebertMaria Margarete KarstenAnna Maria HageAdam David DordevicUlrike Grittner
Published in: Trials (2024)
DRKS (German Clinical Trials Register) DRKS00024015 . Registered on February 15, 2021.
Keyphrases
  • metastatic breast cancer
  • clinical trial
  • patient reported outcomes
  • open label
  • study protocol
  • phase ii
  • randomized controlled trial
  • phase iii
  • squamous cell carcinoma
  • double blind